Short Stature Increases Risk of Cesarean Delivery and Low Birth Weight, Study Finds

India: A study published in the Apollo Medicine revealed that short maternal height (less than 150 cm) is an independent risk factor for cesarean delivery due to cephalopelvic disproportion.

The research also found a significant statistical correlation between shorter mothers and babies with low birth weight. Despite the influence of multiple factors on labor, it is generally reasonable to allow short primigravidae a trial of labor, except in rare cases.

Pregnancy is a natural physiological process that can become complicated by various factors inherent to the woman. Maternal height has long been recognized as an anthropometric factor that can influence obstetric outcomes. Medically, short stature is defined as an adult height that falls more than 2 standard deviations below the mean for one’s gender and age. Several studies, including a meta-analysis by the World Health Organization, identify 145 cm as the standard threshold for determining short stature in women.

Maternal height has long been recognized as an important anthropometric factor influencing obstetric outcomes. In a country like India, where antenatal care is frequently provided by traditional birth attendants (dais) in rural areas, there is a pressing need for a consistent, reliable, and straightforward risk indicator to help prevent unnecessary complications.

Apoorva Anil Gummadi et. al. conducted a study to explore the relationship between maternal height and the mode of delivery, considering other intrapartum factors that affect labor and the subsequent outcomes for both mother and newborn.

For this study, all primigravidae at term gestation (over 37 weeks) with a cephalic presentation at the time of admission to the labor suite and no other comorbidities were included. The mode of delivery, maternal outcomes, and neonatal outcomes were recorded.

The key highlights of the study are:

  • Among the 680 patients, 104 were categorized into the short-stature group with a height of less than 150 cm, while the remaining 576 were in the tall-stature group with a height above 150 cm.
  • The short-stature group had a higher rate of induced labor at 66.35%.
  • There was also a higher incidence of emergency lower-segment cesarean sections due to cephalopelvic disproportion (CPD) in the short-stature group, occurring in 60% of cases.
  • In contrast, the tall-stature group had a higher incidence of normal labor at 32.99%.

The study concluded that short stature is independently associated with an increased risk of labor induction. Additionally, a significant correlation was found between shorter maternal height and the likelihood of babies being born with lower birth weights. Given that labor is influenced by multiple factors, it may be reasonable to allow all primigravidae, regardless of height, a fair trial of labor, except in rare circumstances. Using a specific height cutoff as a screening tool to identify patients who are at a higher risk of obstetrical complications could be beneficial, as height is one of several factors influencing the mode of delivery and labor outcomes.

Reference

Gummadi AA, Sunkaraneni S, Kuchana SK, Kode R, Riyyan M. Association of Maternal Height with Mode of Delivery and Perinatal Outcome. Apollo Medicine. 2024;21(3):206-211. doi:10.1177/09760016241245605maternal height, obstetric outcomes, short stature, labor induction, neonatal outcome, cephalopelvic disproportion, primigravidae, birth weight, trial of labor, screening tool

Powered by WPeMatico

Fragmented Guide Wire Left Inside Patient During PCNL Surgery: Consumer Court Slaps Rs 3 Lakh Compensation on Hospital, Urologist, Duty Doctor

Hyderabad: The Telangana State Consumer Disputes Redressal Commission recently directed a Private Hospital, its Urologist, and a Duty Doctor to pay Rs 3 lakh to a patient, who underwent PCNL (Percutaneous Nephrolithotomy) surgery at the facility. During the surgery, a fractured fragment of the guide wire stayed in her body necessitating another surgery to remove the foreign object.

Although the District Commission had ordered to pay Rs 1 lakh towards medical expenses,  Rs 50,000 towards compensation along with Rs 5000 towards costs, the State Commission enhanced the amount of compensation from Rs 50,000 to Rs 1 lakh and the legal cost amount from Rs 5000 to Rs 20,000.

The history of the case goes back to 2006 when the complainant was suffering from back ache and approached NIMS, Hyderabad on 26.07.2006. After undergoing all the necessary tests, it was diagnosed as Renal Calculi Lt. PCNL to be done. Since the patient was asked to come back after 15 days and was suffering from unbearable pain, she approached the treating hospital i.e. Prathima Hospital on 24.08.2006. 

Consequently, she underwent surgery but despite the operation, her pain and suffering continued. An X-ray was conducted on 02.09.2006 which revealed a foreign body in her left kidney. 

Filing the consumer complaint, the complainant contended that during the operation, the treating Urologist and Duty Doctor conducted the surgery negligently and her suffering and pain have been immense. She approached other doctors and underwent a CT Scan of the abdomen which revealed a foreign body in the left kidney. After that, she was advised to undergo another surgery to remove the foreign body, even though she was not in a financial position to undergo the surgery, submitted the Complainant.

She approached the consumer court and sought compensation for her continuous pain and suffering due to which she also had to suffer business-related loss.

On the other hand, the treating hospital denied the allegations and submitted that the usual period of discharge for PCNL is between 5 to 10 days and the patient was discharged on the 7th day excluding the day of operation. 

The hospital submitted that during the period when the patient was admitted, the dressing was changed from time to time. It was submitted that any surgery which results in an incision will take time to heal and during PCNL, a tube was inserted into the renal pelvis through the calyx and the tube was removed a few days after the operation. The hospital argued that if there was any foreign particle in the body, there would be an immediate infection/abscess warranting surgery.

Further, the hospital submitted that the probe or guide wire used is made of a material that is non-reactionary and it is impossible to perform PCNL without the guide wire. What was informed to the patient was that the particle remained in the body while removing the guide wire was harmless and compatible to the human body and that there was no danger or harm indicated. The small particle that accidentally stuck in the tissue of the kidney area is a small part of the guide wire which is made of insert or bio-compatible material and is therefore of no consequence, submitted the hospital and added that there was no necessity for removal of the foreign body as alleged and hence there was no cause for complaint. Therefore, they prayed to dismiss the complaint.

The urologist submitted that the complainant underwent surgery for the removal of a kidney stone which was ensconced at the central renal area and the same was successfully removed. After the surgery, the usual post-operative care was taken the patient was discharged after the removal of sutures on the healing of the surgical incision. Further, the doctor submitted that he informed the complainant about the retained particle in the kidney and from his extensive knowledge as a Urologist, he assured the Complainant that the particle was harmless.

Referring to the Complainant’s CT Scan abdomen report, he submitted that there was no calculus, no pus or swelling and it was functioning normally. Even though a small piece of guide wire was there in the kidney, it could not be attributed to pain. It was further submitted that if it was the cause, the kidney would have been damaged or formed stones again within two years.

The Duty doctor also stated that the patient did not raise any complaints when she came for follow-up and she never consulted either the Urologist or himself. 

After hearing the arguments by both parties and examining the material on record, the District Commission partly allowed the complaint and directed the doctor and hospital to pay Rs 1 lakh to the Complainant towards medical expenses and Rs 50,000 towards compensation along with Rs 5000 towards costs.

The Complainant challenged the District Commission’s order and argued that the Commission should have allowed the entire compensation as claimed as there was negligence on the part of the doctor.

While considering the case, the State Commission perused the entire medical record and noted that Percutaneous Nephrolithotomy surgery consists of the Urologist making a small incision, a tube is inserted through the incision and a small telescope is passed through the tube to visualize the stone and break it up and remove it.

The Commission noted that in this case, after the PCNL procedure was done, the investigation revealed that small remnant/thread/guide wire outside the pelvis. In the PCNL procedure, the guide wires are indispensable in Urology and fragmentation is there. “However, in this case, it is admitted that it broke and complete removal is imperative, as foreign bodies calcify and obstruct the urinary tract,” observed the Commission.

Further, the Commission considered the medical literature provided by the treating hospital and took note of the fact that the manufacturer is suggested to mark the tip of the wire with a coloured stripe to “enable the physician to assess whether an intact wire was retrieved or not. Immediate action may then be initiated for removal of the foreign body”.

“In conclusion, careful history-taking is necessary to identify patients who have undergone a previous intervention of their urinary system, rendering them at risk of harbouring a forgotten foreign body. Ureteroscopy serves as an appropriate procedure both for diagnostic and therapeutic purposes. Direct visualization of the object is achieved, followed by its prompt removal using appropriate extraction devices. Careful attention should be paid during any invasive procedure of the GUT in order to avoid such cases,” the medical literature further suggested.

The Commission also noted the deposition of the treating doctor stating that “I myself revealed about the remainder of piece of guide wire to the Complainant. I did not record the same in any of my medical file but orally informed to the Complainant. After the discharge of Complainant, I again never saw her or examined her.”

At this outset, the Commission observed that even though the doctors knew about the fractured fragment of the guide wire, in their discharge summary, they failed to advise the Complainant regarding that.

“The primary duty of the doctor who conducted the PCNL procedure must certainly be aware of the perils of guide wire fracture. An understanding of the mechanisms of wire failure would have prevented the unsuspected retained foreign body. An alternate method of removal should have been considered by the Respondents/Opposite Parties when resistance is encountered to have prevented this complication. Although the Respondents/Opposite Parties knew about this fractured fragment of guide wire, in their discharge summary they failed to advice the Appellant/Complainant as to what needs to be done to remove the fragment/foreign body,” noted the Commission.

“A broken guide wire can lead to many complications and can be rebellious to antibiotic treatment. It is always necessary for the Urologist to check the endoscopic equipment at the end of the procedure. Broken guide wires and laser fibres can cause problems for the patient and the surgeon/urologist must be aware of that. The Respondents/Opposite Parties must have been well aware of the implications but have chosen to escape their liability by stating that the guide wire fragment is bio-compatible,” the Commission further observed.

The State Consumer Court noted that even though the treating Urologist claimed that he suggested to the Complainant for removal of the guide wire by conducting the formal operation, this advice was never recorded on the discharge summary and the Appellant/Complainant/patient was under the impression that the fragmented remnants were bio-compatible and would not cause her further pain or suffering.

Telangana SCDRC observed that the District Commission observed the negligence of doctors and the hospital and categorically stated that “When the Opposite Parties noticed presence of foreign body in the kidney at the place of operation which was mentioned in the Discharge Summary they could have removed the guide wire by doing another operation revealing the same to the patient.”

However, the State Commission noted that the District Consumer Court awarded only a meagre compensation of Rs 50,000 and Rs 5,000 towards costs. It observed that

  “When the Respondents/Opposite Parties had the knowledge of the foreign body, it is their duty to record the observation and should have advised the follow up in the discharge summary. Instead, they have failed miserably to take care of the patient who was forced to consult various other specialists and suffer great pain and pay a very high price for undergoing PCNL at their facility.”

From the documents filed by the Complainant, the Commission noted that she consulted another doctor and underwent treatment for h/o retained guide wire fragment and spent a considerable amount towards the emergency admission.

Therefore, the Commission found the grounds valid and enhanced the amount of compensation from Rs 50,000 to Rs 2 lakh and the legal costs from Rs 5,000 to Rs 20,000.

“The grounds urged are valid and we consider it a fit case to enhance the compensation to Rs.2,00,000/- along with costs of Rs.20,000/-,” the Commission noted.

Accordingly, the Commission directed the doctors and hospital to jointly and severally pay to the Appellant/Complainant a sum of Rs 1,00,000 towards medical expenditure, Rs 2,00,000 towards compensation and Rs 20,000 towards costs.

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/telangana-state-consumer-court-246623.pdf

Also Read: Patient died due to medical negligence during blood transfusion: Hospital, 3 doctors directed to pay Rs 20 lakh as compensation

Powered by WPeMatico

Serum Institute of India Gets CDSCO Panel Nod To study Meningococcal Polysaccharide Conjugate Vaccine Freeze-Dried

New Delhi: The vaccine major Serum Institute of India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the phase III clinical trial of Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze-Dried).

However, this nod is subject to the condition that the firm should include more sites covering all geographical areas

This came after Serum Institute of India presented the Phase III clinical trial report of Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze-Dried) of a study titled “A Phase III, randomized, double-blind, controlled, multi-center study to compare immunogenicity and safety of SIIPL Meningococcal ACYWX Conjugate Vaccine (NmCV-5) with that of licensed Meningococcal ACWY Vaccine Menactra in healthy Indian children of 9 months to 17 years of age“.

Vaccines can help prevent meningococcal disease, any illness caused by Neisseria meningitidis bacteria. Meningococcal polysaccharide conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine works by causing body to produce its own protection (antibodies) against the bacteria.

At the recent SEC meeting for vaccine held on July 31, 2024, the expert panel reviewed the Phase III clinical trial report of Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze-Dried) presented by Serum Institute of India.

After detailed deliberation, the committee recommended approval to conduct the Phase-III clinical trial as per the presented protocol, with the condition of including more sites covering all geographical areas.

Also Read: Sun Pharmaceutical Industry gets CDSCO Panel nod to study Fexuprazan HCL tablet for erosive esophagitis

Powered by WPeMatico

Announce NEET SS Exam Schedule in 30 Days: SC tells NMC, junks Plea to Hold Exam this year

New Delhi: The Supreme Court today (August 14) dismissed the plea challenging the National Medical Commission’s (NMC) decision not to hold the National Eligibility-cum-Entrance Test Super Speciality (NEET-SS) 2024 exam this year.

While considering a plea in this regard filed by thirteen doctors under Article 32 of the Constitution, the top court bench of CJI DY Chandrachud, Justices JB Pardiwala, and Manoj Misra observed that the data given by the National Medical Commission (NMC) suggested that at least 40% of the students who appear in the NEET-SS exam are from the immediately preceding batch. 

The Supreme Court bench observed that deferring the exam to the next year would not prejudice the petitioners, who previously appeared in the NEET-SS exam. However, the bench opined that if the exam was held this year, the 2021 Post-Graduate batch students, who will complete their courses in January 2025, would lose their chance.

Although the bench dismissed the plea, it agreed that NMC must decide on the exam schedule at the earliest, the top court bench has directed the Commission to announce the schedule of NEET SS exam within 30 days from today. The Court also held that the exam must be held within three months from January 2025.

A group of thirteen doctors had filed the plea before the Apex Court under Article 32 of the Constitution challenging the NMC’s decision of not holding NEET-SS exam for 2024. 

Also Read:Why No NEET SS in 2024? Supreme Court Seeks Response from NMC, Centre, MCC

NEET SS exam might not be held in 2024 was notified through a communication of the NMC Postgraduate Medical Education Board (PGMEB) dated 23.02.2024. In the said communication the PG Board of NMC had indicated the possibility of not conducting the NEET-SS 2024 exam in the current academic year and postpone it to 2025.

Medical Dialogues had earlier reported that the said communication came to light after NMC shared the minutes of the meeting dated 23.02.2024 while responding to a Right to Information (RTI) application filed by social and political activist Dr. Vivek Pandey.

Filing the RTI, Dr. Pandey had sought the details of the NMC meeting when the decision to prepone the NEET PG 2024 was taken. The concerned meeting was held under the chairmanship of Dr. Vijay Oza, President of PGMEB on 21.02.2024 at 4:00 PM through virtual mode to discuss the examination and counselling schedule for NEET PG 2024 and the pattern of examination for NEET SS.

Regarding the NEET SS 2024 exam date, the minutes of the meeting stated, “Regarding NEET SS-2024, it was decided that as admissions for academic year 2021 for MD/MS and DNB courses were held only a January to May 2022, therefore, NEET SS-2024 may not be conducted in the current year. However exact date of counselling NEET SS- 2024 in the year 2025 will be decided later.”

This decision of not holding the NEET-SS exam for this year was challenged before the Supreme Court. However, as per the latest media report by Live Law, the Supreme Court bench today observed that the NMC’s decision was “fairly equitable” and cannot be termed as “arbitrary”.

While the bench agreed that delaying the exam would cause some hardship to the petitioners, it also observed that such hardship had to be balanced with the other concerns raised by the NMC.

However, the bench accepted the petitioners’ prayer that NMC must take an early decision regarding the schedule for NEET-SS 2024 exam. In this regard, the bench ordered that the schedule should be announced not later than within a period of thirty days from today, factoring the number of students who would be completing their PG courses in January 2025. The Apex Court bench has also ordered that the NEET-SS exam must be held within three months from January 2025.

NMC has reasoned the decision to not hold NEET-SS 2024 exam with the delayed admissions for MD/MS and DNB courses through NEET-PG exam in the year 2021 academic year.

Due to COVID-19, these admissions were held from January 2022 to May 2022 and it ultimately delayed the course completion date to January 2025. As a result, NMC decided to postpone the NEET-SS 2024 exam to accommodate these students.

However, the petitioners’ counsel Advocate Rashmi Nandkumar submitted that only 40% of the students who joined the super speciality courses are from the immediately preceding batch. Therefore, it was argued that not holding NEET-SS in 2024, citing the delayed admission of 2021 PG batch was arbitrary, as it would deprive the remaining 60% of students of their opportunity.

Also Read: NEET SS 2024 may not be held this year: NMC

Powered by WPeMatico

Cardiologist arrested for allegedly sexually assaulting two patients at SCB Medical College Hospital

Bhubaneswar: In a shocking incident, a 37-year-old cardiologist has been arrested for allegedly raping two women patients at SCB Medical College and Hospital in Cuttack.  

The accused is a resident of Bhopal and was working as a senior resident doctor in the cardiology department of SCB Medical College and Hospital in Cuttack. 

The alleged incident took place on Sunday when the two women came to the cardiology department of the government hospital for an echocardiogram test. 

Additional DCP Anil Kumar Mishra told IANS on Tuesday, “On August 11, a complaint was lodged at the Mangalabag police station by a relative of the victim. The complainant, a second-year MBBS student in the same college, alleged that two of his female relatives had gone to the SCB Medical College on Friday for an echocardiogram test. The accused doctor asked them to come on Sunday for the test. As per rules, a woman attendant needs to be present during the echo test, but the accused doctor examined the two women without any lady attendant’s presence.”

Also read- Berlin Doctor arrested for allegedly killing 4 elderly patients, burning their homes

The officer told media persons that both the women came out of the room after the test and told the complainant that they were sexually abused by the doctor during testing.

Speaking to The Indian Express, Mishra said, “During the investigation process, they found that the echocardiogram of the victims should have been done on Friday when they first came to the hospital. The SOP was also not followed as no one was allowed to remain present during the test. Despite the relative of the victims, who is also a MBBS student in the same medical college and hospital requested to be present during test, it was not accepted, which indicates the malafied intention of the accused based on which we have arrested and produced him before the court of law.”

Following this, the relatives of the victim attacked and thrashed the accused doctor which resulted in serious injuries. He is currently admitted to the ICU. Additionally, some junior doctors from the same college, who are friends of the victim’s relative, also attacked the doctor.

The police have initiated a probe into the matter by registering a case under Section 64 (2) and (e) of the Bharatiya Nyaya Sanhita. “The statements of the victims have been recorded,” Mishra said. The accused has been sent to 14-day judicial custody.

Meanwhile, the state Health and Family Welfare Department has constituted a three-member committee to probe the allegations levelled against Singh. “A committee is hereby constituted to inquire the allegations regarding alleged misconduct by a resident doctor of SCB Medical College and Hospital, Cuttack,” read an order issued by the department on Tuesday.

The committee comprises the Director of the Directorate of Medical Education and Training (DMET), Santosh Kumar Mishra, Joint Director of DMET, Roma Rattan, and Sudhansu Sekhar Mishra, the principal of the SCB Medical College and Hospital.

“The committee shall undertake a detailed inquiry into the allegations and recommend appropriate action to the state government,” the order said.

Doctor’s family denies allegations

Refuting the allegations laid against the doctor, the doctor’s father-in-law, stated that the accusations were baseless. He claimed that the ECHO procedure, which necessitates physical contact, was being misconstrued. He called for a review of the CCTV footage and stated that if the doctor is found guilty, appropriate punishment should be taken. He also stressed that the doctor has served at the hospital for three years but never faced any such complaint before.

As per the ETV Bharat news report, the father-in-law said, “The complainant is around 55 to 60 years old and has said that the doctor touched her. Without touching how can ECHO test be performed? If a doctor does not touch a patient, then how can he/she be treated? The complainant is the mother of a medical student and so the doctor went ahead to examine her. 

However, later he was falsely implicated. He was thrashed by his relatives and a few students following which, he became unconscious. After gaining consciousness, an FIR was lodged against him. The CCTV footage should be checked and if he is found guilty, he should face severe punishment. He has spent three years here and no such complaint has ever been levelled against him. Will he misbehave with a 60-year-old lady?” 

Defending the accused doctor, his wife stated that he was targeted as part of a conspiracy and demanded an impartial investigation into the case. She said that her husband was performing the test as a goodwill gesture to a fellow medical student.

“He was alone when assaulted and regained consciousness at around 11 pm. The woman involved is approximately 52 to 55 years old. He was called by the student to perform an ECHO test on her mother, and he went as a goodwill gesture. He wouldn’t have gone if the patient was an outsider. I know he is innocent, and I demand an impartial probe. This is a conspiracy against him,” she added. 

Also read- Kolkata doctor rape-murder case: Doctors to continue nationwide protest, outpatient services hit

Powered by WPeMatico

The NMC issues advisory after Kolkata incident

Amidst the widespread outrage within the medical fraternity in the country prompting doctors and medical students to strike in protest against the unfortunate event in Kolkata where an on-duty PG medico was reportedly brutally raped and murdered, the National Medical Commission (NMC) has issued a statement and an advisory.
In its advisory issued under the authority of Dr B Srinivas, NMC Secretary, the apex medical commission noted that incidents of violence against doctors in medical colleges have been reported in the recent past. Hence, the NMC has directed medical colleges to ensure the safety of doctors by developing a policy towards a safe work environment on the campus for all staff members including doctors and medical students.

For more information, click on the link below:

Powered by WPeMatico

NIRF Ranking 2024 for top medical colleges released

The National Institutional Ranking Framework (NIRF) 2024 has been released for Medical Colleges across India. The medical college ranking has been disclosed in a press conference by Union Education Minister Dharmendra Pradhan. NIRF Rankings 2024 highlights the education standard, infrastructure, faculty, and research facilities at these institutions.
All India Institute of Medical Sciences Delhi has been ranked number 1 across India with a score of 94.46. All India Institute of Medical Sciences (AIIMS), New Delhi occupies the top slot in medicine for the seventh consecutive year, i.e. from 2018 to 2024. Moreover, AIIMS is ranked in 7th position in the Overall category. It was ranked in 6th position in the Overall category in 2023.
For more information, click on the link below:

Powered by WPeMatico

Torrent Pharma is said to seek raising USD 3 billion for KKR stake in JB Chemicals: Report

New York: Torrent Pharmaceuticals Ltd. is looking to raise as much as USD 3 billion from global banks to buy a controlling stake in JB Chemicals & Pharmaceuticals Ltd, Bloomberg News reported citing people familiar with the matter.

Torrent is considering options including dollar and local currency bonds to help fund a potential purchase of KKR & Co.’s 53.8% stake in JB, said the people, asking not to be identified because the discussions are private. Torrent is seeking financing from lenders such as Barclays Plc, Deutsche Bank AG and Standard Chartered Plc, the people said.

JB shares have gained roughly 20% this year, giving the Mumbai-based company a market value of about $3.6 billion.
Deliberations about the stake purchase are ongoing and no final decisions have been made, the people said. Other bidders may still remain interested in acquiring the stake, the people said.
A representative for Torrent didn’t respond to Bloomberg requests for comment. KKR, JB and the banks declined to comment.
KKR has been considering selling its controlling stake in JB, Bloomberg News reported in February. Torrent has been in talks to acquire the US private equity firm’s stake in the company, Moneycontrol reported in April.
Dealmaking activity in India has gained momentum this year as the economy continues to be among the fastest growing in the world.
The flagship company of Torrent Group was incorporated as a small generics drugs company in the early 1970s, according to its website. Its therapeutic areas include cardiovascular, central nervous system and gastrointestinal.

Powered by WPeMatico

Controversy erupts over Silchar Medical College Hospital advisory for female medicos following RG Kar incident

Guwahati: At a time when doctors across the nation are raising voices protesting against the brutal rape and murder of a PG respiratory medicine medico at R G Kar Medical College and Hospital, the Silchar Medical College Hospital (SMCH) in Assam has come under heat after it issued an advisory for female doctors and students that has sparked controversy.

The medical college issued the advisory on Monday restricting female doctors, students and staff movements on the campus for their safety and security in view of the tragic incident at RG Kar Medical College and Hospital. The controversial 8-point safety measures taken by medical college authorities suggest that female doctors, students, and staff should generally avoid isolated, poorly lit, and sparsely populated areas. They should avoid situations where they are alone and refrain from leaving the hostel or lodging rooms during night hours unless necessary, with prior information to the concerned authority.

Also read- Kolkata doctor rape-murder case: Doctors to continue nationwide protest, outpatient services hit

“Avoid going off-campus during late or odd hours. All hostel boarders should abide by the hostel norms and regulations laid down by the institute and administration. Be cautious and avoid associating with individuals who appear unknown or suspicious in nature. Always ensure you have a means of making emergency contact in case of urgent situations. While on duty you should be well composed emotionally, remain alert about the surroundings and should graciously interact with the public, so that you don’t attract the unnecessary attention of unscrupulous people,” stated the advisory notice issued by the principal cum chief superintendent of the institute, Dr Bhaskar Gupta.

Further, the authorities said that any issues or grievances should be immediately communicated to the Chairman/ Members of the Gender Harassment committee, Disciplinary committee, Internal complaint committee, Anti Ragging committee.

Backlash from doctors and students

After the advisory was issued, the medical students and doctors condemned the authorities for its directive and heavily trolled them claiming that it was a ‘misogynistic’ move towards the healthcare professionals. They claimed that the authorities should improve the security arrangements instead of telling the females to stay in their rooms.

Feeling disturbed over the issuance of the advisory, the students claimed that they are hurt and ashamed that instead of providing security to them, the authorities are imposing restrictions on their movement when they have complained about repeated incidents of harassment from the male staff and attendants. They alleged that it was unfair to the women.

SMCH faced backlash from not only its students and doctors but also from netizens across the nation after the advisory went viral on social media. The authorities after receiving huge criticism for their action ultimately decided to cancel this advisory and confirmed that it will issue a new advisory soon. 

Cancelling the present advisory, the authorities in a recent notice said “As NMC has issued an advisory vide no. N-16021/33/2024-IT-NMC(8291616), dt. 13.08.2024, the advisory issued by Silchar Medical College & Hospital administration vide no. SMC/11782, dt. 12.08.2024 stands cancelled. A new advisory will be issued in this regard soon, following NMC norms and with government directives.”

Reaction from netizens

In a post on X, a user wrote “I am stunned after reading this , Instead of strictly Increasing security for Doctors in their medical college & Hospital SMCH ,Silchar has put a notice for Female doctors and staff of their college stating “what they should Do , where they should go and not Instead of safeguarding their doctors they are safeguarding themselves in case any such incidence ever happen in future” ! Can any female doctor feel safe even at their own workplace reading such notices?”

“Blame the victim, don’t blame the rapist. Wow hats off to Government of Assam and administration of Silchar Medical College. Instead of increasing security they are issuing guidelines for the females doctors and medical students. Capital punishment should be there for every rapist. Every rapist should be hanged till death. As a society what have we become?” said a doctor.

“So it is woman’s fault if she gets raped, This letter issued by Silchar Medical College implies that,” asked another user. 

A woman user said “WTF Silchar Medical College! The advisory should be for the men and not women. What kind of a country are we?”

“CONCERNING: The Principal of Silchar Medical College Hospital (SMCH) issued a circular urging the female doctors to be alert around the college campus specifically in areas that are poorly lit and sparsely populated. Is this how we’re going to ensure Safety for Women?” said another user. 

“Assam’s Silchar Medical college has issued an advisory to its female doctors, asking them to avoid isolated places. When are we going to instill this fear in men that if they can’t keep it in their pants they will have to suffer the consequences that can ruin their lives. All these years women were told to do everything to protect themselves and nothing worked, high time these men are taught some lesson!” 

Also read- AIIMS cites code of conduct, Doctors refuse to back down from strike

Powered by WPeMatico

Natco Pharma net profit increases 59 percent to Rs 668 crore in Q1

Hyderabad: Hyderabad-based NATCO Pharma Limited has recorded consolidated
total revenue of Rs 1410.70 Crore for the first quarter ended on 30th June 2024, as against Rs 1160.2 Crore
for the same period last year, reflecting a growth of 21.6 percent in revenue.

The net profit for the period, on a
consolidated basis, was Rs 668.50 Crores as against Rs 420.3 Crore same period last year, showing 59 percent growth in profits.
The growth in revenue and profits were driven primarily by exports formulation business.

The Board of Directors has declared an interim dividend of ₹3.0 per equity share of ₹2.0 each, during Q1
of FY2025

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.

Read also: Migraine drug: Natco Pharma submits application for generic version of Rimegepant Sulfate tablet with USFDA



Powered by WPeMatico